Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
---|
08/30/2006 | CN1272299C Selective oxidation process with enhanced safety |
08/29/2006 | USRE39251 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders |
08/29/2006 | US7098348 Immunosuppressants and apoptosis for cells for anticancer agents |
08/29/2006 | US7098346 Methods and compounds for making coatings, waveguides and other optical devices |
08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
08/29/2006 | US7098243 Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2 |
08/29/2006 | US7098242 administering a compound of dihydroartemisinin dimerized with 1, 2 or 1, 3 or 1, 4 glycol under acidic conditions; antiprotzoal agents, anti-tumor agents |
08/29/2006 | US7098188 Alkali and alkaline earth metal salts of topiramate |
08/29/2006 | CA2273301C Diacetal composition, process for the preparation of the same, nucleating agent for polyolefins containing the same, polyolefin resin compositions, and moldings |
08/24/2006 | WO2006089053A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
08/24/2006 | WO2006086908A1 Process for the preparation of cis-2-acetyl-1, 2, 3, 4, 5, 6, 7, 8-octahydro-1, 2, 8, 8-tetramethylnaphthalene |
08/24/2006 | WO2006056850A3 Chroman compounds |
08/24/2006 | US20060189682 Water soluble prodrugs of COX-2 inhibitors |
08/24/2006 | US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
08/24/2006 | DE102005008021A1 New spiroketal-substituted cyclic ketoenol compounds used for combating animal parasites, undesired plant growth and/or undesired microorganisms |
08/24/2006 | CA2597616A1 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
08/23/2006 | EP1692090A1 Conversion of amine- to carboxyl groups on solid surfaces |
08/23/2006 | EP1126837B1 Fulvic acid and its use in the treatment of various conditions |
08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
08/23/2006 | CN1271061C Process for the preparation of the 14beta-hydroxy-baccatin III -1,14-carbonate |
08/22/2006 | US7094913 Reacting a trimethylsilanylmethyl-allenol derivative by the intramolecular Prins cyclization using Lewis acid to synthesize 1-methyl-2,3-dimethylene-8-oxa-bicyclo[3.2.1]octane |
08/22/2006 | US7094805 Total synthesis of merrilactone A |
08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
08/22/2006 | US7094378 Method and apparatus for inactivation of biological contaminants using photosensitizers |
08/22/2006 | CA2299503C Anti-first-pass effect compounds |
08/17/2006 | WO2006085562A1 Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome |
08/17/2006 | WO2006028977A3 Chiral spiro compounds and their use in asymmetric catalytic reactions |
08/17/2006 | WO2006000555A3 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
08/17/2006 | WO2004094647A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
08/16/2006 | EP1690883A1 Pellicle and novel fluorinated polymer |
08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
08/16/2006 | EP1689727A2 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto |
08/16/2006 | EP1689697A1 Process for the production of anhydrosugar alcohols |
08/15/2006 | US7091239 DNA polymerase inhibitors, mikanolide and dihydromikanolide |
08/15/2006 | US7091226 Cancer treatment with epothilones |
08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
08/10/2006 | WO2006081771A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same |
08/10/2006 | WO2006081659A1 Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k) |
08/09/2006 | EP1688419A1 Novel compound and medicinal composition |
08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
08/09/2006 | EP1465897B1 Process for preparing protease inhibitor intermediates |
08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
08/09/2006 | CN1816514A Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
08/09/2006 | CN1814601A Artemisine derivative with immune suppression action and medicinal composition |
08/09/2006 | CN1814600A Compound with antitumor activity, and its preparing method and use |
08/09/2006 | CN1268622C New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg |
08/09/2006 | CN1268351C Sugar absorption inhibitors and process for producing the same |
08/09/2006 | CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration |
08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
08/08/2006 | US7087641 4β-1″-[(2″-substituted benzoyl) anilino]podophyllotoxin analogues useful as anticancer agents |
08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
08/03/2006 | WO2006081072A1 Antagonists of the mglu receptor and uses thereof |
08/03/2006 | WO2006080439A1 Tricyclic compound |
08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
08/03/2006 | US20060173199 Stereoselective Ring Closure olefin Metathesis (RCM) reaction and Enzymatic Resolution (ER) for the production of optically pure synthetic intermediates during an organic synthesis; provides 3,6-dihydro-2H-pyrans |
08/03/2006 | US20060173069 Therapeutic agent for hyperpotassemia and bone disease |
08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
08/02/2006 | EP1685135A1 Tetrahydro-furo¬3,4-d|dioxole compounds and compositions and method for inhibiting platelet aggregation |
08/02/2006 | EP1485389B1 Antiparasitic artemisinin derivatives (endoperoxides) |
08/02/2006 | EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
08/02/2006 | EP1140811B1 Novel herbicides |
08/02/2006 | EP0862428B1 Ginkgolides for inhibition of membrane expression |
08/02/2006 | CN1812785A New effector conjugates, process for their production and their pharmaceutical use |
08/02/2006 | CN1810809A Coumarether compound and new use of its composition |
08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
08/01/2006 | US7084152 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof |
07/27/2006 | WO2006077975A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
07/27/2006 | US20060167284 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
07/27/2006 | DE112004001860T5 Disulfid-,Sulfid-,Sulfoxid- und Sulfonderivate von cyclischen Zuckern und Verwendungen davon Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof |
07/26/2006 | EP1683056A2 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
07/26/2006 | CN1807430A Preparation method for extracting oridonin from rabdosia |
07/26/2006 | CN1807403A Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use |
07/26/2006 | CN1266154C Method for producing pyromellitic dianhydride |
07/26/2006 | CN1266142C Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring |
07/25/2006 | CA2369095C Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
07/20/2006 | WO2006076564A1 Synthesis of himbacine analogs |
07/20/2006 | WO2006076452A2 An exo-selective synthesis of himbacine analogs |
07/20/2006 | CA2594807A1 An exo-selective synthesis of himbacine analogs |
07/20/2006 | CA2594741A1 Synthesis of himbacine analogs |
07/19/2006 | CN1803869A Preparation method of polar group-containing absorptive resin and application thereof in preparation of high-purity sanguinarin |
07/19/2006 | CN1803801A Method for preparing ellagic acid by pomegranate rind |
07/19/2006 | CN1264845C 1,2,4,5-pyromellitic anhydride preparation |
07/18/2006 | US7078541 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation |
07/18/2006 | US7078538 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate |
07/18/2006 | US7078432 Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate |
07/13/2006 | US20060154982 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases such as cancer, psoriasis, arteriosclerosis or is at risk of restenosis of the coronary arteries after vascular surgery |
07/13/2006 | US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora) |
07/12/2006 | EP1394156B1 Chromene compound |
07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
07/12/2006 | CN1800188A Method for separating and preparing triptolide diol from tripterygium wilfordii |
07/12/2006 | CN1800187A Taspine alkaline preparation method and uses in preparing medicine for treating tumour |
07/12/2006 | CN1263763C Process for extracting ginkgolide |
07/12/2006 | CN1263762C Desugar and deaminosugar FR-008 derived polyketone antibiotics |
07/12/2006 | CN1263761C Process for isolation and purification of epothilones |